What better way to mark this than a Simply Oncology Bladder Cancer episode with the irrepressible
@alisonbirtle.bsky.social
🎙️We discuss peri-operative treatment & NIAGARA trial
#BladderCancer
@tapiajc.bsky.social @achoud72.bsky.social
@abcuk.bsky.social
What better way to mark this than a Simply Oncology Bladder Cancer episode with the irrepressible
@alisonbirtle.bsky.social
🎙️We discuss peri-operative treatment & NIAGARA trial
#BladderCancer
@tapiajc.bsky.social @achoud72.bsky.social
@abcuk.bsky.social
Changing practice .
Thanks to all the 75 uk centres who contributed at least one patient , the trials teams and all the families and patients especially Andrew Winterbottom amd Chris Davies ,lay members on trial group
Changing practice .
Thanks to all the 75 uk centres who contributed at least one patient , the trials teams and all the families and patients especially Andrew Winterbottom amd Chris Davies ,lay members on trial group
We covered ‘The Triple Question in mHSPC in the last episode 🎯
🎙️This time we cover all things metastatic castrate resistant prostate cancer🎙️
@alisonbirtle.bsky.social
@simplyoncology.bsky.social
We covered ‘The Triple Question in mHSPC in the last episode 🎯
🎙️This time we cover all things metastatic castrate resistant prostate cancer🎙️
@alisonbirtle.bsky.social
@simplyoncology.bsky.social
Pls like and share
go.bsky.app/HyLFqvg
Pls like and share
go.bsky.app/HyLFqvg
➡️ Use a radiosensitiser wherever possible, doesn't matter which one
➡️ Highest level of evidence for #BCON & #5FUMMC
👏🏽👏🏽👏🏽👇🏽
www.sciencedirect.com/science/arti...
➡️ Use a radiosensitiser wherever possible, doesn't matter which one
➡️ Highest level of evidence for #BCON & #5FUMMC
👏🏽👏🏽👏🏽👇🏽
www.sciencedirect.com/science/arti...
https://buff.ly/3CJA5bO
So here's a throw back pic to #EMUC 2018 presenting the POUT trial data.
So here's a throw back pic to #EMUC 2018 presenting the POUT trial data.